I build medical devices and strategies that bring better therapies to more people.
With roots in cardiovascular support, diagnostics and early-stage device innovation, my training and experience span engineering, medicine, and technology translation.
I trained in engineering at MIT, earned my MD at HMS and completed medical training at MGH.
At MicroPort, I serve as a C-suite executive to lead the build-out of global infrastructure across cardiovascular device portfolios. I am establishing new functions and governance systems to support the company's transformation to more integrated global operations. Through Pathline, I invest in and advise early-stage medical device companies in critical care, circulatory support, and continuous monitoring by providing capital alongside hands-on guidance in conception, clinical strategy, and global execution.
If you’re working on breakthrough medtech, emerging therapies, or early-stage teams and want a partner or strategic collaborator, please reach out to connect.
